Status:
COMPLETED
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") Dysfunction
Lead Sponsor:
University College, London
Collaborating Sponsors:
European Commission
University of Luxembourg
Conditions:
Parkinson Disease
Parkinsonism
Eligibility:
All Genders
18+ years
Brief Summary
Parkinson's disease (PD) is a progressive neurological disorder that is increasingly common with age, with the incidence rising from approximately 4 people per 10,000 in their forties to 2 in 100 over...
Detailed Description
Parkinson's disease (PD) is a progressive neurological disorder that is increasingly prevalent with age, with the incidence rising from approximately 4 people per 10,000 in their forties to 2 in 100 o...
Eligibility Criteria
Inclusion
- Diagnosed with PD, or a related condition (e.g. Parkinson's plus, dystonia, tremor) or healthy control participant
- Age 18 years or over
Exclusion
- 1\. Lack of capacity to consent to participate in the project
Key Trial Info
Start Date :
August 18 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03421899
Start Date
August 18 2017
End Date
April 1 2020
Last Update
May 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCL Institute of Neurology, Department of Clinical Neurosciences, Upper 3rd Floor, Royal Free Hospital, Rowland Hill Street
London, United Kingdom, NW3 2PF